Tulane COVID Antibody Testing (or Long COVID/CSI studies)

Here you will find results from spike antibody testing for subjects participating in the Tulane IRB (2020-585) approved study: Seroepidemiology and Immunity of COVID-19 in Southern Louisiana. This includes the Tulane University Long COVID Study.

Instructions: Look up your testing results for presence of spike antibodies by your unique study ID. If you are unclear which study ID is yours or have other question, please contact the study team at SeroEpiCovid@tulane.edu or cobaltcovid@wave.tulane.edu. The date of visit is also included for your unique study ID

 Information about the spike antibody test: 

  1. The test we are using is not a perfect test, it is not FDA approved, and is a test being used for research purposes only. 
  2. This is NOT a test which should be used for a medical diagnosis. 
  3. There may be false positives (where you test positive, but you have not actually been exposed) and false negatives (where you test negative, but you actually have been exposed). 
  4. At this time, we do not know if having antibody protects you from being infected again and/or becoming sick with the virus. 
  5. You should not use the results from this research study to inform your medical treatment. 
  6. Results will be posted for the last 4 months of testing only.

Thank you for your participation in this study! 

Antibody Testing Results:

Updated: 1/12/2024

Results Code Spike antibodies Visit date
6298 Positive 6/20/23
968 Positive 6/22/23
5487 Positive 7/19/23
7121 Positive 7/19/23
1374 Positive 8/8/23
5292 Positive 9/13/23
4956 Positive 9/26/23
1471 Positive 9/26/23
9694 Positive 9/26/23
7711 Positive 9/26/23
6092 Positive 10/3/23
3267 Positive 10/3/23
6363 Positive 10/3/23
8172 Positive 10/4/23
2961 Positive 10/9/23
7381 Positive 10/9/23
6937 Positive 10/9/23
7998 Positive 10/17/23
5863 Positive 10/17/23
9884 Positive 10/17/23
9997 Positive 10/18/23
5083 Positive 10/18/23
1447 Positive 10/20/23
9209 Positive 10/23/23
1826 Positive 10/23/23
8431 Positive 10/24/23
5518 Positive 10/24/23
183 Positive 10/24/23
1511 Positive 10/24/23
2572 Positive 10/25/23
2062 Positive 10/25/23
622 Positive 10/25/23
8620 Positive 10/25/23
5217 Positive 10/25/23
4008 Positive 10/25/23
1203 Positive 10/31/23
2690 Positive 10/31/23
7028 Positive 10/31/23
4497 Positive 10/31/23
9633 Positive 10/31/23
5465 Positive 11/3/23
213 Positive 11/7/23
2375 Positive 11/7/23
318 Positive 11/7/23
731 Positive 11/7/23
8203 Positive 11/7/23
8821 Positive 11/8/23
1819 Positive 11/8/23
3464 Positive 11/8/23

Publications or Manuscripts From Ongoing U54 Serpent Project COVID Studies:

  1. Huang Z, Ning B, Yang HS, Youngquist BM, Niu A, Lyon CJ, Beddingfield BJ, Fears AC, Monk CH, Murrell AE, Bilton SJ, Linhuber JP, Norton EB, Dietrich ML, Yee JK, Lai W, Scott JW, Yin XM, Rappaport J, Robinson JE, Saba NS, Roy CJ, Zwezdaryk KJ, Zhao Z, Hu TY. Sensitive tracking of circulating viral RNA through all stages of SARS-CoV-2 infection. J Clin Invest. 2021 Feb 9;. doi: 10.1172/JCI146031. [Epub ahead of print] PubMed PMID: 33561010.
  2. Schieffelin JS, Norton EB, Kolls JK. What should define a SARS-CoV-2 “breakthrough” infection?. J Clin Invest. 2021 Jun 15;131(12). doi: 10.1172/JCI151186. PubMed PMID: 33974565; PubMed Central PMCID: PMC8203469.
  3. Dietrich M.L., Norton E.B., Elliott D., Smira A.R., Rouelle J.A., Bond N.G., Aime-Marcelin K., Prystowsky A., Kemnitz R., Sarma A., Himmelfarb S.T., Sharma N., Stone A.E., Craver R., Lindrose A.R., Smitley L.A., Uddo R.B., Myers L., Drury S.S., Schieffelin J.S., Robinson J.E., Zwezdaryk K.J. SARS-CoV-2 Seroprevalence Rates of Children in Louisiana During the State Stay at Home Order. Journal of Clinical Virology Plus. 2021 Dec; 1:4. PMID: 35262027. Published online 2021 Nov 14. doi: 10.1016/j.jcvp.2021.100047
  4. Amelie E.Murrell, Ewono Eyoh, Jeffrey G. Shaffer, Monika L. Dietrich, Ivy V. Trinh, Thomas J. Yockachonis, Shuangyi Bai, Crystal Y. Zheng, Celia V. Mayne, Sofia E. Cabrera, Anyssa Aviles-Amaro, Addison E. Stone, Saraswatie Rambaran, Sruti Chandra, Debra H.Elliott, Ashley R. Smira, Sara N. Harris, Katharine E. Olson, Samantha J. Bilton, Medea J.Gabriel, Nicole D. Falgout, Emily J. Engel, Alisha D. Prystowsky, Bo Ning, Tony Hu, Jay K.Kolls, Samuel J. Landry, Stacy S. Drury, John S. Schieffelin, Kevin J. Zwezdaryk, James E.Robinson, Bronwyn M. Gunn, Elizabeth B. Norton. Antibody Responses In Non-Severe SARS-CoV-2 Infections Are Driven By CD4+ T cells and Age. In submission, Preprint: medRxiv 2022.04.22.22274032; doi:https://doi.org/10.1101/2022.04.22.22274032. 
  5. Seifert SN, Bai S, Fawcett S, Norton EB, Zwezdaryk KJ, et al. (2022) An ACE2-dependent Sarbecovirus in Russian bats is resistant to SARS-CoV-2 vaccines. PLOS Pathogens 18(9): e1010828. https://doi.org/10.1371/journal.ppat.1010828
  6. Bo Ning 1,2, Sutapa Chandra1,2, Juniper Rosen1,2, Evan Multala1,2, Melvin Argrave1,2, Lane Pierson1,2, Ivy Trinh3, Chris J. Lyon1,2, Matthew Escarra4, Stacy Drury 5,6, Elizabeth B. Norton3 and Tony Hu1,2* .Evaluation of SARS-CoV-2 specific T cell activation with a point-of-care on-chip IGRA. Accepted at ACS Nano. 

     

Results Flyers:

CSI March 2022 Newsletter

Comments are closed.